APP and Alzheimer disease: A week of chronic intracerebroventricular (ICV) IGF2 infusion increased basal forebrain cholinergic neurons while increasing hippocampal ChAT expression in a transgenic APP/PS1 animal model of AD (Mellott et al., 2014).